Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participants
Open Access
- 12 May 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 32 (17), 2161-2167
- https://doi.org/10.1093/eurheartj/ehr126
Abstract
We aimed to asses the generalizability of two ‘all-comers’ randomized clinical trials (AC-RCTs) in patients undergoing percutaneous coronary intervention (PCI). Recently two large AC-RCT's comparing drug-eluting stents were performed in our institution (LEADERS and RESOLUTE-III). During the inclusion period of these trials 1242 consecutive PCI patients were treated of whom 579 (48%) were actually included. The most important reasons for non-participation were inability to provide informed consent (33.5%), refused to participate (19%), or patient met one of the other exclusion criteria (26.9%). Trial participants more frequently had stable angina (42.5 vs. 34.4%) and less frequently acute myocardial infarction as indication for PCI (31.4 vs. 42.4%) than non-participants. Hypertension (52.8 vs. 49.1%) and hypercholesterolaemia (56.3 vs. 49.1%) were seen more frequently in trial participants; heart failure was less common (2.1 vs. 4.4%). A significant difference in 30-day mortality was observed between AC-RCT participants and non-participants [0.7 vs. 4.5% events; adjusted hazard ratio (aHR) 0.18 and 95% confidence interval (CI) 0.06–0.52]. One-year mortality was also lower (3.1 vs. 6.9% events; aHR: 0.51 and 95% CI: 0.29–0.91, but 1-year mortality in 48 h survivors was similar (3.1 vs. 4.2% events; aHR: 0.74 and 95% CI: 0.41–1.34). Applying the all-comers design did not result in inclusion of all consecutive patients, as only half of the target population was enrolled. It should be noted, however, that this design included more patients than observed in classical RCTs. AC-RCT participants and non-participants were different in terms of baseline characteristics and outcome.Keywords
This publication has 7 references indexed in Scilit:
- Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary StentsThe New England Journal of Medicine, 2010
- Drug-eluting stents: is new necessarily better?The Lancet, 2008
- Why Patients Continue to Participate in Clinical ResearchJAMA Internal Medicine, 2008
- Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary RevascularizationEuropean Heart Journal, 2006
- Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart FailureEuropean Heart Journal, 2005
- Clinical Trials and the Real World: Selection Bias and Generalisability of Trial ResultsCardiovascular Drugs and Therapy, 2002
- Patient comprehension and reaction to participating in a double-blind randomized clinical trial (ISIS-4) in acute myocardial infarction.Archives of Internal Medicine, 2000